Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Windtree Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for WINT.
You can purchase shares of Windtree Therapeutics (NASDAQ:WINT) through any online brokerage.
Other companies in Windtree Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Galecto (NASDAQ:GLTO), Dermata Therapeutics (NASDAQ:DRMA), Synaptogenix (NASDAQ:SNPX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
Windtree Therapeutics has a consensus price target of $7.00.
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $1.1798 last updated April 30, 2025 at 4:01 PM EDT.
There are no upcoming dividends for Windtree Therapeutics.
Windtree Therapeutics’s Q4 earnings are confirmed for Tuesday, May 13, 2025.
There is no upcoming split for Windtree Therapeutics.
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.